St injected .6 months ago Injected within last 6 months Urine drug test, positive results, n ( ) Opiate Cocaine AUDITb10 (2?4) 48 (92) 95 (70?20) 4 (8) 19 (12?6) 43 (83)11 (2?1) 51 (93) 80 (70?10) 4 (7) 21 (10?0) 44 (80)8 (15) 18 (35) 26 (50)2 (4) 31 (56) 22 (40)9 (17) 18 (35) 10 (19)12 (22) 24 (44) 10 (18)score 8, n ( )HIV relatedEmergency department visit or hospitalization in prior 3 months, n
St injected .6 months ago Injected within last 6 months Urine drug test, positive results, n ( ) Opiate Cocaine AUDITb10 (2?4) 48 (92) 95 (70?20) 4 (8) 19 (12?6) 43 (83)11 (2?1) 51 (93) 80 (70?10) 4 (7) 21 (10?0) 44 (80)8 (15) 18 (35) 26 (50)2 (4) 31 (56) 22 (40)9 (17) 18 (35) 10 (19)12 (22) 24 (44) 10 (18)score 8, n ( )HIV relatedEmergency department visit or hospitalization in prior 3 months, n
Statistically significant (Table 3). Among those in whom resistance testing was done, the percentages with new drug resistance mutations were similar in DAART and SAT. The M184V and K103N mutations in reverse transcriptase were acquired most commonly. No subject acquired new protease inhibitor-associated mutations or mutations to more than one drug class.Intervention DeliveryDAART was intended to
N ( ) Homeless, self-described, n ( ) Receiving public assistance or social security disability, n ( ) Employed, n ( ) CES-D short-form scorea, median (IQR) 44 (85) 8 (15) 47 (42?2) 29 (56) 20 (39) 41 (79) 8 (15) 11 (5?6) 44 (80) 11 (20) 47 (41?1) 27 (49) 12 (23) 50 (91) 8 (15) 11 (6?5) 19 (37) 17 (33) 4 (8) 7 (13) 5 (10) 27 (52) 20 (36) 18 (33) 4 (7) 7 (13) 6 (11) 24 (44)Substance abuse relatedDu
Ow-up will be needed to determine whether HCV cure through the use of direct-acting antivirals among HIV/ HCV coinfected elite controllers will make the risk for complications among these patients similar to their HIV monoinfected counterparts. Further studies will also be needed to determine the effects of antiretroviral therapy in this group of patients coupled to its risk/benefit ratio. Whereas
Use of the monitors and asked them to return at 1 week, 4 weeks, and 8 weeks to download data from the monitors. Research assistants did not review recorded adherence data with participants. The protocolEthics StatementEach participant provided written informed consent and the study protocol was approved by the Johns Hopkins Medicine Institutional Review Board (IRB), the University of Maryland IRB
Use of the monitors and asked them to return at 1 week, 4 weeks, and 8 weeks to download data from the monitors. Research assistants did not review recorded adherence data with participants. The protocolEthics StatementEach participant provided written informed consent and the study protocol was approved by the Johns Hopkins Medicine Institutional Review Board (IRB), the University of Maryland IRB
G directly administered antiretroviral therapy with self-administered therapy in opioid treatment programs, Baltimore, Maryland, 2006?010.Differencea (95 CI)SAT (N = 52) Virologic and immunologic outcomes Average proportion with HIV RNA ,50 copies/mL during interventionb Average proportion with HIV RNA ,400 copies/mL during intervention Average change from baseline in log10 HIV RNA during interve